Abstract
Wenjun Li, Fei Guo, Tianming Zhang, Beili Liu, Hongyan Tao
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019
2023
COPD detection in lung cancer screening programmes: "hitting two birds with one stone"
10.1183/13993003.01294-2022 · 2022
Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation
10.1186/s13046-024-03026-7 · 2024
Immune cell regulatory networks in chronic obstructive pulmonary disease: mechanistic analysis from innate to adaptive immunity
2025
Chronic obstructive pulmonary disease reprograms the lung into an immune organ through trained immunity, cell death networks, and immune checkpoint dysregulation
2026
CD8+ T cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice
10.4049/jimmunol.178.12.8090 · 2007
Unraveling the immune landscape of chronic obstructive pulmonary disease: insights into inflammatory cell subtypes, pathogenesis, and treatment strategies
10.3390/ijms26073365 · 2025
Research progress of Treg/Th17 in the treatment of chronic obstructive pulmonary disease with lung cancer]
2019
The immune contexture in human tumours: impact on clinical outcome
ror
Confidence 99%
openalex
Confidence 95%
datacite
Confidence 0%
10.1038/nrc3245 · 2012
Changes in Th1/Th2-producing cytokines during acute exacerbation chronic obstructive pulmonary disease
10.1177/0300060518781642 · 2018
Imbalances of Th17 and treg cells and their respective cytokines in COPD patients by disease stage
2014
Regulatory T cells in Respiratory health and diseases
10.1155/2019/1907807 · 2019
Exploring the relationship between Treg-mediated risk in COPD and lung cancer through mendelian randomization analysis and scRNA-seq data integration
10.1186/s12885-024-12076-1 · 2024
Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema
10.1126/scitranlsmed.3000154 · 2009
IL-17A is elevated in end-stage chronic obstructive pulmonary disease and contributes to cigarette smoke-induced lymphoid neogenesis
10.1164/rccm.201410-1861oc · 2015
Microbiota promotes chronic pulmonary inflammation by enhancing IL-17A and autoantibodies
10.1164/rccm.201504-0779oc · 2016
The role of CD8 + T lymphocytes in chronic obstructive pulmonary disease: a systematic review
10.1007/s00011-020-01408-z · 2021
Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15
10.4049/jimmunol.1000006 · 2010
Systemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPD
10.1183/09031936.00079611 · 2012
A unique cellular organization of Human distal airways and its disarray in chronic obstructive pulmonary disease
10.1164/rccm.202207-1384oc · 2023
Combining single-cell RNA sequencing of peripheral blood mononuclear cells and exosomal transcriptome to reveal the cellular and genetic profiles in COPD
10.1186/s12931-022-02182-8 · 2022
Activation of CD8(+) T cells in chronic obstructive pulmonary disease lung
10.1164/rccm.202305-0924oc · 2023
Effector memory CD8+ T cells are resistant to apoptosis
10.1196/annals.1398.017 · 2007
Single-cell transcriptome analysis deciphers the CD74-mediated immune evasion and tumour growth in lung squamous cell carcinoma with chronic obstructive pulmonary disease
10.1002/ctm2.1786 · 2024
Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease
10.1016/j.celrep.2023.112525 · 2023
Inflammatory endotypes in COPD
10.1111/all.13760 · 2019
New insights into the immunology of chronic obstructive pulmonary disease
10.1016/s0140-6736(11)60988-4 · 2011
Macrophages: their role, activation and polarization in pulmonary diseases
10.1016/j.imbio.2017.11.001 · 2018
Macrophage polarization and reprogramming in acute inflammation: a redox perspective
2022
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
10.1016/j.jaci.2016.05.011 · 2016
Oxidative stress in COPD
10.1378/chest.12-2664 · 2013
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
10.1016/j.jaci.2012.12.1564 · 2013
Cellular and molecular mechanisms of asthma and COPD
10.1042/cs20160487 · 2017
The nature of small-airway obstruction in chronic obstructive pulmonary disease
10.1056/nejmoa032158 · 2004
Effects of cigarette smoke on toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages
10.1111/cei.12289 · 2014
NF-kappaB signaling in chronic inflammatory airway disease
10.3390/biom5031266 · 2015
Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model
10.1126/scitranslmed.3002042 · 2011
Nuclear factor-kappa B and its role in inflammatory lung disease
10.1016/j.cbi.2021.109568 · 2021
Crosstalk between airway epithelial cells and mast cells in airway inflammation
10.1186/s12931-025-03388-2 · 2025
Increased IgA expression in lung lymphoid follicles in severe chronic obstructive pulmonary disease
10.1164/rccm.201802-0352oc · 2019
Challenges in circulating tumor cell detection by the CellSearch system
10.1016/j.molonc.2015.12.002 · doi-reference
Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
10.1038/nm.3984 · doi-reference
Smart City electricity load forecasting using Greylag Goose optimization-enhanced time series analysis
10.1007/s13369-025-10647-3 · doi-reference
El-Kenawy EM. Optimizing solar and wind forecasting with iHow optimization algorithm and multi-scale attention networks
10.1038/s41598-026-39632-y · doi-reference
Serum proteomics profiling identifies a preliminary signature for the diagnosis of early-stage lung cancer
10.1002/prca.202200093 · doi-reference
Urine proteome profiling predicts lung cancer from control cases and other tumors
10.1016/j.ebiom.2018.03.009 · doi-reference
Application of proteomics in non-small-cell lung cancer
10.1586/14789450.2016.1121813 · doi-reference
Clinical application of mass spectrometry-based proteomics in lung cancer early diagnosis
10.1002/prca.201900138 · doi-reference
Serum proteomic profiling in patients with chronic obstructive pulmonary disease
10.2147/copd.s413924 · doi-reference
Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres
10.1183/23120541.00658-2020 · doi-reference
From COPD to smoke-related arteriopathy: the mechanical and immune-inflammatory landscape underlying lung cancer distant spreading-A narrative review
10.3390/cells14161225 · doi-reference
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
10.1038/srep31726 · doi-reference
PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab
10.1016/j.lungcan.2018.04.001 · doi-reference
Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
10.1038/s41698-021-00203-1 · doi-reference
Construction of IMMS containing multi-site liposomes for dynamic monitoring of blood CTC in patients with osimertinib-resistant non-small-cell lung cancer and its mechanism
10.2174/1871520623666221107140624 · doi-reference
Circulating tumor cells with aberrant ALK copy number predict progression-free survival during Crizotinib treatment in ALK-rearranged non-small cell lung cancer patients
10.1158/0008-5472.can-16-3072 · doi-reference
Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients
10.1371/journal.pone.0085350 · doi-reference
Prognostic role of circulating tumor cells in patients with EGFR-mutated or ALK-rearranged non-small cell lung cancer
10.1111/1759-7714.12631 · doi-reference
Revisiting biomarker discovery by plasma proteomics
10.15252/msb.20156297 · doi-reference
Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients
10.1177/17588359231167818 · doi-reference
Evaluation of circulating tumor cells and related events as prognostic factors and surrogate biomarkers in advanced NSCLC patients receiving first-line systemic treatment
10.3390/cancers6010153 · doi-reference
High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis
10.1088/1478-3975/9/1/016004 · doi-reference
Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer
10.1200/jco.2010.28.7045 · doi-reference
Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy
10.1158/2159-8290.cd-15-1483 · doi-reference
Identification and bioinformatic analysis of CircRNAs in the plasma of patients with very severe chronic obstructive pulmonary disease
10.1186/s12890-023-02513-5 · doi-reference
MicroRNA-34c is associated with emphysema severity and modulates SERPINE1 expression
10.1186/1471-2164-15-88 · doi-reference
Therapeutic RNA strategies for chronic obstructive pulmonary disease
10.1016/j.tips.2020.04.007 · doi-reference
circ-Sirt1 controls NF-κb activation via sequence-specific interaction and enhancement of SIRT1 expression by binding to miR-132/212 in vascular smooth muscle cells
10.1093/nar/gkz141 · doi-reference
Hsa_circ_0006872 promotes cigarette smoke-induced apoptosis, inflammation and oxidative stress in HPMECs and BEAS-2B cells through the miR-145-5p/NF-κb axis
10.1016/j.bbrc.2020.11.044 · doi-reference
Knockdown of circFOXO3 ameliorates cigarette smoke-induced lung injury in mice
10.1186/s12931-021-01883-w · doi-reference
CircRNAs in cancer metabolism: a review
10.1186/s13045-019-0776-8 · doi-reference
CircRNA inhibits DNA damage repair by interacting with host gene
10.1186/s12943-020-01246-x · doi-reference
Role of circular RNAs in brain development and CNS diseases
10.1016/j.pneurobio.2020.101746 · doi-reference
Regulation of circRNA biogenesis
10.1080/15476286.2015.1020271 · doi-reference
Machine learning model for circulating tumor DNA detection in chronic obstructive pulmonary disease patients with lung cancer
10.21037/tlcr-23-633 · doi-reference
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
10.1038/s41591-022-02047-z · doi-reference
Liquid biopsy for lung cancers: an update on recent developments
10.21037/atm.2019.03.28 · doi-reference
Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA
10.1371/journal.pone.0194630 · doi-reference
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
10.1038/nature22364 · doi-reference
Liquid biopsies: genotyping circulating tumor DNA
10.1200/jco.2012.45.2011 · doi-reference